Skip to the beginning of the images gallery

Glaxo: The acquisition of Wellcome

Canals, Jordi ; Bardolet Urgellès, David

Reference: ASE-386-E
Number of pages: 18
Geographic Setting: Estados Unidos
Publication Date: Jun 1, 1998
Source: IESE (España)
Type of Document: Case

Grouped product items
Format	Language	Reference	Use	Qty	Price	Preview
pdf	English	ASE-386-E			As low as €8.20	Preview

You already have a subscription

To order please contact the person in charge of academic purchases in your university.

You'll be able to order once your profile has been validated.

Description

This case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioning in a changing industry; the evaluation of growth opportunities and M&A as strategic decisions.

Keywords

investment Mergers and Acquisitions Strategy